Skip to main content

Animations

MJFF Publications

1741 - 1750 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2022
  • 2024
  • 2023
  • 2024
  • 2023
  • Summary Details
    OPEN
    Title: Biochemical Fractionation of Human α-Synuclein in a Drosophila Model of Synucleinopathies
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3390/ijms25073643
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Early deficits in an in vitro striatal microcircuit model carrying the Parkinson’s GBA-N370S mutation
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00694-2
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Self-supervised learning for human activity recognition using 700,000 person-days of wearable data
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-024-01062-3
    Citation Count: 72
  • Summary Details
    OPEN
    Title: α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06630-9
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease
    Journal Name: Frontiers in Immunology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fimmu.2024.1349030
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Atypical antipsychotic use and mortality risk in Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.013
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Development and characterization of a non-human primate model of disseminated synucleinopathy
    Journal Name: Frontiers in Neuroanatomy
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3389/fnana.2024.1355940
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer disease
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neulet.2023.137330
    Citation Count: 9
  • Summary Details
    OPEN
    Title: APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41586-024-07185-7
    Citation Count: 227
  • Summary Details
    OPEN
    Title: In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloids
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41592-023-02080-x
    Citation Count: 47
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.